あすか製薬ホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/07/24 | 2,361 | 2,378 | 2,338 | 2,354 | -13 | -0.5% | 49,800 |
| 2024/07/23 | 2,410 | 2,410 | 2,361 | 2,367 | -16 | -0.7% | 32,100 |
| 2024/07/22 | 2,430 | 2,430 | 2,383 | 2,383 | -4 | -0.2% | 48,300 |
| 2024/07/19 | 2,382 | 2,405 | 2,375 | 2,387 | +14 | +0.6% | 34,800 |
| 2024/07/18 | 2,365 | 2,398 | 2,363 | 2,373 | -2 | -0.1% | 59,800 |
| 2024/07/17 | 2,398 | 2,403 | 2,358 | 2,375 | -23 | -1% | 70,500 |
| 2024/07/16 | 2,425 | 2,430 | 2,383 | 2,398 | -23 | -1% | 56,400 |
| 2024/07/12 | 2,380 | 2,443 | 2,370 | 2,421 | +21 | +0.9% | 51,900 |
| 2024/07/11 | 2,411 | 2,425 | 2,359 | 2,400 | ±0 | ±0% | 60,500 |
| 2024/07/10 | 2,405 | 2,413 | 2,374 | 2,400 | -11 | -0.5% | 63,900 |
| 2024/07/09 | 2,419 | 2,447 | 2,388 | 2,411 | +13 | +0.5% | 64,200 |
| 2024/07/08 | 2,420 | 2,420 | 2,390 | 2,398 | -21 | -0.9% | 57,800 |
| 2024/07/05 | 2,403 | 2,428 | 2,400 | 2,419 | -3 | -0.1% | 42,000 |
| 2024/07/04 | 2,463 | 2,470 | 2,419 | 2,422 | -41 | -1.7% | 49,600 |
| 2024/07/03 | 2,475 | 2,492 | 2,446 | 2,463 | -12 | -0.5% | 51,100 |
| 2024/07/02 | 2,477 | 2,491 | 2,450 | 2,475 | -23 | -0.9% | 66,100 |
| 2024/07/01 | 2,500 | 2,550 | 2,484 | 2,498 | +17 | +0.7% | 84,400 |
| 2024/06/28 | 2,526 | 2,526 | 2,468 | 2,481 | -45 | -1.8% | 83,800 |
| 2024/06/27 | 2,632 | 2,636 | 2,526 | 2,526 | -156 | -5.8% | 155,700 |
| 2024/06/26 | 2,706 | 2,720 | 2,639 | 2,682 | +26 | +1% | 119,300 |
| 2024/06/25 | 2,600 | 2,660 | 2,570 | 2,656 | +149 | +5.9% | 145,500 |
| 2024/06/24 | 2,500 | 2,530 | 2,475 | 2,507 | +30 | +1.2% | 87,500 |
| 2024/06/21 | 2,447 | 2,480 | 2,440 | 2,477 | +48 | +2% | 103,600 |
| 2024/06/20 | 2,395 | 2,429 | 2,391 | 2,429 | +16 | +0.7% | 38,100 |
| 2024/06/19 | 2,431 | 2,439 | 2,393 | 2,413 | +21 | +0.9% | 49,700 |
| 2024/06/18 | 2,420 | 2,431 | 2,382 | 2,392 | -7 | -0.3% | 61,400 |
| 2024/06/17 | 2,410 | 2,422 | 2,377 | 2,399 | ±0 | ±0% | 52,600 |
| 2024/06/14 | 2,325 | 2,413 | 2,325 | 2,399 | +117 | +5.1% | 100,800 |
| 2024/06/13 | 2,331 | 2,360 | 2,278 | 2,282 | -61 | -2.6% | 50,500 |
| 2024/06/12 | 2,358 | 2,359 | 2,322 | 2,343 | -11 | -0.5% | 41,400 |
| 2024/06/11 | 2,324 | 2,361 | 2,324 | 2,354 | +45 | +1.9% | 44,500 |
| 2024/06/10 | 2,267 | 2,320 | 2,251 | 2,309 | +65 | +2.9% | 33,400 |
| 2024/06/07 | 2,258 | 2,258 | 2,200 | 2,244 | -19 | -0.8% | 53,800 |
| 2024/06/06 | 2,295 | 2,338 | 2,253 | 2,263 | -32 | -1.4% | 25,400 |
| 2024/06/05 | 2,328 | 2,400 | 2,287 | 2,295 | -1 | ±0% | 40,400 |
| 2024/06/04 | 2,327 | 2,338 | 2,290 | 2,296 | -40 | -1.7% | 46,100 |
| 2024/06/03 | 2,388 | 2,406 | 2,336 | 2,336 | -23 | -1% | 38,400 |
| 2024/05/31 | 2,319 | 2,369 | 2,281 | 2,359 | +65 | +2.8% | 45,300 |
| 2024/05/30 | 2,319 | 2,319 | 2,267 | 2,294 | -29 | -1.2% | 48,600 |
| 2024/05/29 | 2,377 | 2,395 | 2,295 | 2,323 | -37 | -1.6% | 64,000 |
| 2024/05/28 | 2,340 | 2,390 | 2,338 | 2,360 | +2 | +0.1% | 50,400 |
| 2024/05/27 | 2,287 | 2,358 | 2,287 | 2,358 | +80 | +3.5% | 56,900 |
| 2024/05/24 | 2,293 | 2,296 | 2,270 | 2,278 | -28 | -1.2% | 21,800 |
| 2024/05/23 | 2,310 | 2,318 | 2,262 | 2,306 | +46 | +2% | 50,400 |
| 2024/05/22 | 2,257 | 2,311 | 2,240 | 2,260 | +3 | +0.1% | 63,100 |
| 2024/05/21 | 2,282 | 2,320 | 2,251 | 2,257 | -27 | -1.2% | 45,400 |
| 2024/05/20 | 2,273 | 2,315 | 2,268 | 2,284 | +7 | +0.3% | 38,200 |
| 2024/05/17 | 2,266 | 2,308 | 2,256 | 2,277 | -25 | -1.1% | 37,000 |
| 2024/05/16 | 2,327 | 2,348 | 2,299 | 2,302 | -39 | -1.7% | 41,200 |
| 2024/05/15 | 2,450 | 2,450 | 2,330 | 2,341 | -103 | -4.2% | 66,400 |
251～
300
件表示中 / 1062件
類似銘柄と比較する
現在ご覧いただいている「あすかＨＤ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| あすかＨＤ | 246,300円 | +16.9% | +33.2% | 2.23% | 13.43倍 | 1.07倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
| ハートシード | 355,500円 | +174.2% | - | 0.00% | - | 10.76倍 |
|
慶応大学発ベンチャー。ｉＰＳ細胞を使い独自の心筋再生用心筋球で重症心不全治療を目指す |
| ＪＣＲファーマ | 60,000円 | +14.3% | - | 3.33% | 24.39倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| ヘリオス | 63,700円 | +150.0% | - | 0.00% | - | 33.79倍 |
|
ｉＰＳ細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
| タウンズ | 53,100円 | +4.6% | +6.1% | 5.27% | 9.06倍 | 3.36倍 |
|
院内で行う迅速抗原検査の体外診断薬専業大手。新型コロナ、インフルなど呼吸器感染症首位 |
市場注目の銘柄
チャート関連のコラム
